Abstract
Fibroblast-like synoviocytes (FLS) play a pathogenic role in rheumatoid arthritis (RA). STAT3 signaling is activated in FLS of RA patients (RA-FLS), which in turn causes RA-FLS hyperproliferation. RL is a traditional remedy for treating inflammatory diseases in China. It comprises Rosae Multiflorae Fructus and Lonicerae Japonicae Flos. A standardized ethanolic extract of RL (RLE) has been shown to exert anti-arthritic effects in collagen-induced arthritis (CIA) rats. Some constituents of RLE were reported to inhibit JAK2/STAT3 signaling in rat FLS. Here, we determined whether RLE inhibits FLS hyperproliferation, and explored the involvement of STAT3 signaling in this inhibition. In joints of CIA rats, RLE increased apoptotic FLS. In IL-6/sIL-6R-stimulated RA-FLS, RLE reduced cell viability and evoked cell apoptosis. In synovial tissues of CIA rats, RLE lowered the protein level of phospho-STAT3. In IL-6/sIL-6R-stimulated RA-FLS, RLE inhibited activation/phosphorylation of STAT3 and JAK2, decreased the nuclear localization of STAT3, and downregulated protein levels of Bcl-2 and Mcl-1. Over-activation of STAT3 diminished RLE’s anti-proliferative effects in IL-6/sIL-6R-stimulated RA-FLS. In summary, RLE inhibits hyperproliferation of FLS in rat and cell models, and suppression of STAT3 signaling contributes to the underlying mechanisms. This study provides further pharmacological groundwork for developing RLE as a modern anti-arthritic drug.
Similar content being viewed by others
Introduction
Rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, affects around 1% of the world population and degrades quality of life of those who have it1. Fibroblast-like synoviocytes (FLS) play a pathogenic role in RA. FLS of RA patients (RA-FLS) are characterized by hyperproliferation and resistance to apoptosis, which results in synovial hyperplasia2. Hyperproliferation of RA-FLS leads to the destruction of cartilage and bone of RA patients2. Signal transducer and activator of transcription 3 (STAT3) signaling is activated in RA-FLS, which in turn promotes proliferation and inhibits apoptosis of RA-FLS3. Elevated interleukin-6 (IL-6) is commonly found in sera and the synovial fluid of RA patients4. Binding of IL-6 to its receptors activates Janus kinase 2 (JAK2), an upstream kinase of STAT3, which leads to the phosphorylation of STAT35. Phosphorylated STAT3 forms homodimers and then translocate into the nucleus to transcriptionally upregulate survival genes such as Bcl-2 and Mcl-13. Therefore, STAT3 signaling has been proposed as a target for treating RA6. Although current anti-arthritic drugs, e.g. certolizumab and tofacitinib, can effectively alleviate inflammation and joint deterioration in RA patients, they have unacceptable side effects, including serious infections and tuberculosis7. Multi-component herbal medicines have been recognized as alternatives for treating RA8.
An herbal formula RL, comprising Rosae Multiflorae Fructus (RMF, the dried fruit of Rosa multiflora Thunb.) and Lonicerae Japonicae Flos (LJF, the dried newly bloomed flower or flower bud of Lonicera japonica Thunb.), was written by a traditional Chinese medicine (TCM) doctor Sun Simiao in c. 652 A.D. (Tang dynasty of China) for managing inflammatory and/or infectious diseases9,10. RMF11 and LJF12,13, owing to their low toxicity, are consumed as nutraceuticals in diverse cultures. They are also used as folk remedies for treating RA10,14,15,16. Pharmacological studies showed that RMF17 and LJF-containing formulas18,19 can attenuate collagen-induced arthritis (CIA). We previously found that a standardized ethanolic extract of RL (RLE for short) has anti-RA effects in CIA rats20. Chlorogenic acid, a compound used for controlling RLE’s quality20, has been shown to be able to inhibit the proliferation of IL-6-stimulated rat FLS and suppress JAK2/STAT3 signaling21. In this study, we investigated the effects of RLE on apoptosis of FLS in joints of CIA rats, and on proliferation of, and apoptosis in, interleukin-6/soluble interleukin-6 receptor (IL-6/sIL-6R)-stimulated RA-FLS. We also investigated the involvement of STAT3 signaling in these effects.
Results
RLE increases apoptotic FLS in joints of CIA rats
RA-FLS are resistant to apoptosis2. We examined the effect of RLE on apoptotic rate of FLS in joints of CIA rats using the TUNEL assay and immunohistochemistry (IHC) staining of cleaved caspase-3. DNA fragmentation resulting from apoptotic signaling cascades can be detected by TUNEL assays. Cleaved caspase-3 is an apoptosis marker. In normal and model groups, TUNEL-positive FLS (Fig. 1A) and cleaved caspase-3-positive FLS (Fig. 1B) in synovia of rat joints were very few, and there was no difference between the two groups. TUNEL assays showed that RLE dose-dependently and significantly induced apoptosis (Fig. 1A). In IHC staining assays, although RLE was not able to significantly increase apoptotic FLS at 330 mg/kg, it exerted significant effect at 660 mg/kg (Fig. 1B). The positive control indomethacin significantly increased TUNEL-positive FLS (Fig. 1A) and cleaved caspase-3-positive FLS (Fig. 1B) as well. These findings indicate that RLE promotes apoptosis of FLS in joints of CIA rats in a dose-dependent manner.
RLE inhibits proliferation of, and induces apoptosis in, IL-6/sIL-6R-stimulated RA-FLS
IL-6 signaling activates STAT3 in RA-FLS, which has been implicated in hyperproliferation and resistance to apoptosis of RA-FLS3. To determine the effects of RLE on proliferation of patient-derived synoviocytes, CCK-8 and crystal violet staining assays were performed. RLE dose- and time-dependently reduced viability of IL-6/sIL-6R-stimulated synoviocytes in CCK-8 assays (Fig. 2A). The anti-proliferative effects of 450 μg/mL of RLE were comparable to that of 100 μM of indomethacin (Fig. 2A). Crystal violet staining visualized RLE’s inhibitory effects on RA-FLS proliferation (Fig. 2B). To determine the effects of RLE on the proliferation of normal cells, mouse fibroblast L929 and human normal liver-derived MIHA cells were used. In the presence of IL-6/sIL-6R, the anti-proliferative effects of RLE in both L929 and MIHA lines were weak (Fig. 2C,D) and less potent than in RA-FLS (Fig. 2A,B). To determine the effects of RLE on apoptosis of synoviocytes, Annexin V-FITC/PI double staining assays were conducted. RLE dose-dependently induced apoptosis in IL-6/sIL-6R-stimulated synoviocytes (Fig. 3A). RLE’s apoptotic effects were verified by its ability to dose-dependently cleave caspase-3 and caspase-9 (Fig. 3B). As compared with the solvent treatment, IL-6/sIL-6R stimulation did not significantly affect synoviocyte apoptotsis (data not shown). These findings indicate that RLE inhibits proliferation of, and induces apoptosis in, IL-6/sIL-6R-stimulated RA-FLS.
RLE lowers the protein level of p-STAT3 in synovia of CIA rats
In the mechanistic studies, we found that protein level of phospho-STAT3 (Tyr 705) in synovial tissues was higher in CIA rats than in normal rats, and RLE treatments significantly and dose-dependently down-regulated the level of this protein (Fig. 4). Indomethacin also inhibited phosphorylation of STAT3 in synovia of CIA rats (Fig. 4), which is in line with a previous report22. These data indicate that RLE inhibits STAT3 activation in synovia of CIA rats.
RLE inhibits STAT3 signaling in IL-6/sIL-6R-stimulated RA-FLS
In cell assays, IL-6/sIL-6R stimulation time-dependently promoted the activation/phosphorylation at site Tyr705 of STAT3 in RA-FLS, with a peak at 40 min (Fig. 5A). Synoviocytes stimulated with IL-6/sIL-6R for 40 min were used as the cell model in subsequent assays. Further cellular assays showed that RLE dose-dependently suppressed IL-6/sIL-6R-induced phosphorylation of STAT3 and JAK2 without affecting protein levels of STAT3 and JAK2 in synoviocytes (Fig. 5B). It was also observed that RLE decreased STAT3 nuclear localization induced by IL-6/sIL-6R (Fig. 5C); and reversed IL-6/sIL-6R-induced up-regulation of protein levels of Mcl-1 and Bcl-2 (Fig. 5D) in synoviocytes. These results indicate that RLE inhibits STAT3 signaling in RA-FLS.
Over-activation of STAT3 diminishes RLE’s inhibitory effect on proliferation of IL-6/sIL-6R-stimulated RA-FLS
To determine whether STAT3 signaling plays a role in RLE’s effects on proliferation of RA-FLS, we over-activated STAT3 in RA-FLS by transducing STAT3C (A662C, N664C mutant), a constitutively active STAT3 variant23, into the cells. Microscopic analyses showed that synoviocytes were successfully transduced (Fig. 6A). Immunoblotting showed that transduction of STAT3C plasmid caused a remarkable elevation in levels of STAT3 and phospho-STAT3 (Tyr705) (Fig. 6A), showing an over-activation of STAT3. Upon STAT3 over-activation, inhibitory effects of 150 and 300 μg/mL of RLE on the proliferation of IL-6/sIL-6R-stimulated synoviocytes were decreased 10.25% and 29.78%, respectively (Fig. 6B). These findings indicate that inhibition of STAT3 signaling contributes to RLE’s inhibitory effect on RA-FLS proliferation.
Discussion
In a previous study, we found that RLE reduces paw swelling and arthritis clinical scores, and alleviates bone destruction in CIA rats without observable adverse reactions20. Moreover, RLE improves body weight gain of CIA rats20. In the present study, we found that RLE promotes apoptosis of pathogenic FLS in CIA rats (Fig. 1A,B), and inhibits proliferation (Fig. 2A,B) of, and induces apoptosis (Fig. 3A) in, IL-6/sIL-6R-stimulated RA-FLS. These findings of our previous and the present studies indicate that RLE has potential to be developed as an effective and safe modern drug for treating RA.
We previously observed that RLE inhibits diverse toll-like receptor 4 (TLR4) signaling components in LPS-stimulated RAW264.7 and THP-1 cells24; and that RLE lowers the protein level of TLR4 and inhibits phosphorylation/activation of TLR4 downstream transcription factors, NF-κB p65 (nuclear factor-κB p65), AP-1 (activator protein-1) and IRF3 (interferon regulatory factor 3) in joints of CIA rats20. We also observed that RLE reduces production of pro-inflammatory cytokines IL-6, TNF-α and IL-1β which are regulated by transcription factors NF-κB, AP-1 and IRF3 in joint tissues and sera of CIA rats20. These findings indicate that inhibiting TLR4 signaling is one of the mechanisms of the anti-RA effects of RLE. Pro-inflammatory cytokines IL-6, TNF-α and IL-1β are also regulated by the transcription factor STAT3. These cytokines can be produced by RA-FLS25. It is reported that chlorogenic acid, a quality control marker of RLE20, can suppress JAK2/STAT3 signaling in rat FLS21. Thus, in this study, we investigated the involvement of STAT3 signaling in RLE’s inhibitory effects on FLS proliferation. We found that RLE inhibits STAT3 activation in synovia of CIA rats (Fig. 4) and suppresses STAT3 signaling in cell models (Fig. 5B–D). Over-activation of STAT3 attenuates the anti-proliferative effects of RLE in IL-6/sIL-6R-stimulated synoviocytes (Fig. 6B). Results of the present study indicate that inhibiting STAT3 signaling to suppress RA-FLS hyperproliferation is another anti-RA mechanism of RLE (Fig. 7).
RA-FLS play a key role in RA-associated bone erosion26. In RA-FLS, IL-6/sIL-6R induces expression of receptor activator of nuclear factor kappa-B ligand (RANKL), which is crucial for osteoclastogenesis27. In a previous study, we found that RLE alleviates bone erosion in CIA rats20. Further studies are warranted to determine whether RLE inhibits RANKL expression in IL-6/sIL-6R-stimulated RA-FLS by inhibiting the STAT3 pathway.
In summary, we for the first time found that RLE has pro-apoptotic effect in FLS of CIA rats, and has anti-proliferative and pro-apoptotic effects in IL-6/sIL-6R-stimulated RA-FLS; and that inhibition of the STAT3 signaling pathway contributes to the underlying mechanisms (Fig. 7). This study provides further pharmacological justifications for the traditional use of RL in treating inflammatory diseases, and provides additional pharmacological groundwork for developing RLE as a modern anti-arthritic agent.
Materials and methods
Preparation of RLE
Collection and authentication of RMF and LJF were the same as in a previous report9. Voucher specimens of the two herbs (RMF: YS6, LJF: JYH) were deposited at our School. As originally recorded in Tang dynasty of China, patients with inflammatory diseases were asked to drink rice wine in which the two ingredient herbs of RL had been soaked10. This suggests that active constituents in the formula are lipophilic. For use in this work, we extracted RL with different concentrations of ethanol and compared the effects of the extracts on nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated macrophages. Results showed that among the extracts, RLE exhibited the most potent inhibitory effects (Fig. S1). RLE was extracted with absolute ethanol20; its yield was 15.2%. Contents of chlorogenic acid and gallic acid in RLE were quantified using an HPLC method (Fig. S2).
TUNEL assays
Knee joints of CIA and normal rats that had been dosed with drugs or vehicle in a previous study20 were collected. All care and handling of animals were performed in accordance with the recommendations of the Committee on the Use of Human & Animal Subjects of the Hong Kong Baptist University. The protocol was approved by the Department of Health, Hong Kong [Reference number: (19-21) in DH/SHS/8/2/6 Pt. 3]. The ARRIVE guidelines for reporting animal research were fully implemented. In that study, there were three groups of RLE intragastrically (i.g.)-dosed rats; of those three groups, results from only two (330 mg/kg group and 660 mg/kg group) were used in this study. The two groups exhibited stronger anti-arthritic effects than the 165 mg/kg group20. We also included the normal control (0.5% carboxymethyl cellulose-Na, i.g.), model (0.5% carboxymethyl cellulose-Na, i.g.) and positive control (2.5 mg/kg of indomethacin, i.g.) groups in the present study. There were 8 rats in each group, for a total of 48 rats. The joints were fixed and sectioned as described previously28. The sections were processed for TUNEL assays (In Situ Apoptosis Detection Kit, USA) following the manufacturer's instructions. Cryosection imaging was performed as described29. TUNEL assay results were quantified by counting the DAPI and TUNEL-positive cells in three individual fields using ImageJ software. Percentages of TUNEL-positive cells in synovia of rat joints were calculated using the following equation: TUNEL-positive cells (%) = TUNEL-positive cells/DAPI-positive cells × 100%. The researcher (J-Y Wu) assigned to calculate percentages of TUNEL-positive cells was blinded to the experimental design.
IHC staining
Knee joints of rats were fixed and sectioned. IHC staining was performed as described29. The primary cleaved caspase-3 antibody was bought from Cell Signaling Technology (#9579; USA) and the secondary antibody was bought from Abcam (#ab205719; Cambridge, UK). Cryosection imaging was performed as described in the TUNEL assay section. IHC staining results were quantified by counting the DAPI and cleaved caspase-3-positive cells in three individual fields using ImageJ software. Percentages of cleaved caspase-3-positive cells in synovia of rat joints were calculated using the following equation: cleaved caspase-3-positive cells (%) = cleaved caspase-3-positive cells/DAPI-positive cells × 100%. The researcher (J-Y Wu) assigned to calculate percentages of cleaved caspase-3-positive cells was blinded to the experimental design.
Cell culture
Patient-derived synoviocytes RA-FLS were obtained from Cell Applications (USA). L929 and MIHA cells were purchased from American Type Culture Collection (USA). Cells were maintained in high glucose Dulbecco’s modified Eagle’s medium (GIBCO, MA, USA) supplemented with 10% fetal bovine serum (GIBCO) and 1% penicillin/streptomycin (GIBCO) at 37 °C in a humidified atmosphere of 5% CO2.
Cell Counting Kit-8 (CCK-8) and crystal violet staining assays
CCK-8 assay30 was performed to detect RLE’s effects on the proliferation of RA-FLS, L929 cells and MIHA cells. 100 ng/mL each of IL-6/sIL-6R (PeproTech, NY, USA) was used to stimulate cells in this study. RA-FLS seeded in 96-well plates (5,000 cells/well) were pre-treated with RLE (0–600 μg/mL) or 100 μM of indomethacin (positive control) for 1 h and then treated with IL-6/sIL-6R for 24 or 48 h. L929 or MIHA cells seeded in 96-well plates (5,000 cells/well) were pre-treated with RLE (0–600 μg/mL) for 1 h and then treated with IL-6/sIL-6R for 24 h. Crystal violet staining assay31 was also performed to determine RLE’s effects on the proliferation of RA-FLS. Cells seeded in 60-mm dishes (2 × 105 cells/dish) were pre-treated with RLE (0, 150, 300 μg/mL) for 1 h and then treated with IL-6/sIL-6R for 48 h.
Apoptosis assay
RLE’s apoptotic effects on RA-FLS were measured by Annexin V-FITC/PI double staining32 using an Apoptosis Detection Kit (#ab14085; Abcam). Synoviocytes seeded in 6-well plates (1 × 105 cells/well) were pre-treated with RLE (0, 150, 300 μg/mL) for 1 h and then treated with IL-6/sIL-6R for 24 h. Flow cytometric analysis was performed using a BD Accuri C6 flow cytometer (BD Biosciences, USA).
Western blot analysis
Proteins were prepared from ankle synovial tissues of rats and cultured cells. Whole cell, cytoplasmic and nuclear extracts were prepared and immunoblotting was conducted as described previously32. Primary antibodies JAK2 (#3230), STAT3 (#12640), cleaved caspase 9 (#52873), phospho-JAK2 (Tyr1007/1008, #3771), phospho-STAT3 (Tyr705, #9131), Myeloid cell leukemia 1 (Mcl-1, #94296) and lamin B1 (#12586) were obtained from Cell Signaling Technology; GAPDH (#sc365062)and B-cell lymphoma 2 (Bcl-2, #sc7382) antibodies were obtained from Santa Cruz Biotechnology (USA). Cleaved caspase 3 (#ab2302) and HRP-conjugated secondary antibodies (#ab7090, #ab97040) were obtained from Abcam.
Cell transient transduction and viability assays of transduced cells
Adenovirus expressing GFP-Flag-tagged STAT3C (Ad-STAT3C) and control adenovirus (Ad-Empty vector) with green fluorescent protein (GFP) as a transduction indicator were prepared by Vigene Biosciences (Shandong, China). STAT3C (A662C, N664C mutant) is a constitutively active STAT3 variant23. RA-FLS were seeded in 100-mm dishes (6 × 105 cells/dish) and transduced with Ad-STAT3C (7.8 × 107 pfu/mL) or Ad-Empty vector (7.8 × 107 pfu/mL); after 24 h, the supernatant was discarded and replaced with fresh medium. After a 12-h incubation, transduced RA-FLS were used for cell viability assays. RA-FLSEmpty vector and RA-FLSSTAT3C seeded in 96-well plates (5,000 cells/well) were separately pre-treated with RLE (0, 150, 300 μg/mL) for 1 h and then treated with IL-6/sIL-6R for 48 h. Cell viability was assessed using CCK-8 assays30. Viability of RLE-untreated RA-FLSEmpty vector or RLE-untreated RA-FLSSTAT3C was regarded as 100%.
Statistical analysis
GraphPad software (GraphPad Prism 5.0, USA) was used for statistical analyses. Data are presented as mean ± standard deviation (SD), and were analyzed using one-way ANOVA followed by Dunnett's test. P < 0.05 was considered statistically significant.
References
Wasserman, A. Rheumatoid arthritis: Common questions about diagnosis and management. Am. Fam. Physician 97, 455–462 (2018).
Mor, A., Abramson, S. B. & Pillinger, M. H. The fibroblast-like synovial cell in rheumatoid arthritis: A key player in inflammation and joint destruction. Clin. Immunol. 115, 118–128 (2005).
Krause, A., Scaletta, N., Ji, J.-D. & Ivashkiv, L. B. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J. Immunol. 169, 6610–6616 (2002).
Houssiau, F. A., Devogelaer, J. P., Van Damme, J., De Deuxchaisnes, C. N. & Van Snick, J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784–788 (1988).
Hashizume, M. & Mihara, M. The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis 20, 11 (2011).
Oike, T. et al. Stat3 as a potential therapeutic target for rheumatoid arthritis. Sci. Rep. 7, 10965 (2017).
Ramiro, S. et al. Safety of synthetic and biological DMARDs: A systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum Dis. 76, 1101–1136 (2017).
Yang, C. L., Or, T. C., Ho, M. H. & Lau, A. S. Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clin. Rev. Allergy Immunol. 44, 284–300 (2013).
Cheng, B. C. Y. et al. A herbal formula consisting of Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages. J. Ethnopharmacol. 153, 922–927 (2014).
Nanjing University of Chinese Medicine. Chinese Materia Medica Grand Dictionary. (Shanghai Scientific & Technical Publishers, 1977).
Cheng, B. C. Y. et al. The genus Rosa and arthritis: Overview on pharmacological perspectives. Pharmacol. Res. 114, 219–234 (2016).
Li, Y., Li, W., Fu, C., Song, Y. & Fu, Q. Lonicerae japonicae flos and Lonicerae flos: A systematic review of ethnopharmacology, phytochemistry and pharmacology. Phytochem. Rev. 2, 1–61 (2019).
Yokota, J. Application of natural ingredients to preventive medicine. Yakugaku Zasshi 137, 571–580 (2017).
Ye, J. Q. Xiandai Shiyong Zhongyao (Yilin Shuju Press, Yilin, 2006).
Liu, J. & Sun, Y. How does Chinese medicine target cytokine imbalance in rheumatoid arthritis?. Chin. J. Integr. Med. 19, 874–880 (2013).
Yu, M. A clinical study of treatment of rheumatoid arthritis with the Qing-Re-Huo-Xue-Tang. Asia-Pac. Tradit. Med. 9, 149–150 (2013).
Wu, J. et al. Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats. J. Ethnopharmacol. 157, 45–54 (2014).
Li, J. et al. Herbal formula Xian-Fang-Huo-Ming-Yin regulates differentiation of lymphocytes and production of pro-inflammatory cytokines in collagen-induced arthritis mice. BMC Complement. Altern. Med. 17, 1–13 (2017).
Wang, Y. et al. Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms. Pharmacogn. Mag. 11, 242 (2015).
Cheng, B. C. Y. et al. A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats. Sci. Rep. 6, 20042 (2016).
Lou, L. et al. Chlorogenic acid induces apoptosis to inhibit inflammatory proliferation of IL-6-induced fibroblast-like synoviocytes through modulating the activation of JAK/STAT and NF-κB signaling pathways. Exp. Ther. Med. 11, 2054–2060 (2016).
Ban, J. O. et al. Anti-arthritis effects of (E)-2, 4-bis (p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway. Br. J. Pharmacol. 171, 2900–2912 (2014).
Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295–303 (1999).
Cheng, B. C. Y. et al. A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits the production of inflammatory mediators and the IRAK-1/TAK1 and TBK1/IRF3 pathways in RAW 264.7 and THP-1 cells. J. Ethnopharmacol. 174, 195–199 (2015).
Noss, E. H. & Brenner, M. B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223, 252–270 (2008).
Korb-Pap, A., Bertrand, J., Sherwood, J. & Pap, T. Stable activation of fibroblasts in rheumatic arthritis—causes and consequences. J. Rheumatol. 55, 64–67 (2016).
Hashizume, M., Hayakawa, N. & Mihara, M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17. Rheumatology (Oxford) 47, 1635–1640 (2008).
Jia, Y. et al. Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase. J. FASEB J. 32, 3398–3410 (2018).
Liu, Y. X. et al. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment. Pharm. Res. 142, 115–126 (2019).
Zhang, S. Q. et al. Oleanolic acid enhances neural stem cell migration, proliferation, and differentiation in vitro by inhibiting GSK3β activity. Cell Death Discov. 5, 48 (2018).
Tse, A.K.-W. et al. Sensitization of melanoma cells to alkylating agent-induced DNA damage and cell death via orchestrating oxidative stress and IKKβ inhibition. Redox. Biol. 11, 562–576 (2017).
Su, T. et al. An ethanolic extract of ampelopsis radix exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling in vitro. Front. Pharmacol. 8, 227 (2017).
Acknowledgements
This work was supported by Shenzhen Science and Technology Innovation Commission (JCYJ20160229210327924, JCYJ20170817173608483 and JCYJ20200109150719846), National Natural Science Foundation of China (81673649, 8187141799 and 81803788), Research Grants Council of Hong Kong (12102918 and 12101519) and Guangdong Provincial Department of Science and Technology (2020A1515010579).
Author information
Authors and Affiliations
Contributions
Y.-J.C., Y.-X.L., and J.-Y.W. performed the experiments, analyzed the data and wrote the draft; Y.-J.C., Y.-X.L., J.-Y.W., C.-Y.L., M.-M.T., L.B., X.-Q.F., J.-K.L., J.-Y.C., C.-L.Y., Y.-P.W., J.-X.B., W.Y and X.-Q.W. participated in the experimental work; Y.-J.C. and Z.-L.Y designed the experiments; Z.-L.Y conceived and supervised this study, and finalized the manuscript; and all authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, YJ., Liu, YX., Wu, JY. et al. A two-herb formula inhibits hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes. Sci Rep 11, 3850 (2021). https://doi.org/10.1038/s41598-021-83435-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-83435-2
- Springer Nature Limited
This article is cited by
-
Inflammatory-associated apoptotic markers: are they the culprit to rheumatoid arthritis pain?
Molecular Biology Reports (2022)